Web Results

en.wikipedia.org/wiki/David_Farragut

David Glasgow Farragut /ˈfærəɡət was a flag officer of the United States Navy during the American Civil War. He was the first rear admiral, vice admiral, and admiral in the United States Navy. He is remembered for his order at the Battle of Mobile Bay usually paraphrased as "Damn the torpedoes, full speed ahead" in U.S. ..... Farragut triumphed over the opposition of heavy batteries in Fort Morgan and ...

www.ncbi.nlm.nih.gov/pubmed/21670448

Jun 13, 2011 ... Thol F(1), Damm F, Lüdeking A, Winschel C, Wagner K, Morgan M, Yun H, Göhring G, Schlegelberger B, Hoelzer D, Lübbert M, Kanz L, Fiedler ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3232272

Ley et al. described an adverse prognostic impact of the mutation for patients in AML. .... There were no significant differences in patients with low (n=79) versus high .... Thol F, Damm F, Lüdeking A, Winschel C, Wagner K, Morgan M, et al.

www.ncbi.nlm.nih.gov/pubmed/22343920

Feb 17, 2012 ... Damm F(1), Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, ... Morgan MA, Cross NC, Preudhomme C, Birnbaum D, Bernard OA, ...

ascopubs.org/doi/full/10.1200/jco.2011.35.4894

DNMT3A mutated v wild-type, 1.42, 1.06 to 1.91 .02, 1.59, 1.15 to 2.21 .005 ..... F Damm, M Heuser, M Morgan , etal: Single nucleotide polymorphism in the ...

www.nature.com/leu/journal/v26/n2/full/leu2011200a.html

Aug 9, 2011 ... Correspondence: Dr MA Morgan, Department of Hematology, Hemostasis, .... II vs favorable), de novo vs secondary AML, and ND4 mutation status. ..... Thol F, Damm F, Ludeking A, Winschel C, Wagner K, Morgan M et al.

ascopubs.org/doi/full/10.1200/jco.2010.31.1118

High MLL5 expression correlated with longer OS (5-year OS, 61% v 39%; P = . 007) and .... Fujiki et al showed that MLL5 binds to retinoic acid receptor α (RARα ) and .... F Damm, M Heuser, M Morgan Single nucleotide polymorphism in the ...

ascopubs.org/doi/abs/10.1200/jco.2009.23.0342

Michael Morgan .... Frederik Damm et al., J Clin Oncol, 2010 ... Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell ...

onlinelibrary.wiley.com/doi/10.1111/bjh.12298/full

Mar 25, 2013 ... In contrast to findings in adult AML (Damm et al, 2012), evaluation of ... status ( e.g. MT-ND4wildtype versus heteroplasmic or homoplasmic ...